The glioma microenvironment is enriched with inflammatory mediators/chemotactic factors such as monocyte chemoattractant proteins (MCP-1, -3), glial cell-derived neurotrophic factor (GDNF), and colony-stimulating factor (CSF-1, -2). The gene discussed is CSF2; the disease is central nervous system cancer.